Skip to main content
Clinical Trials/NCT04151095
NCT04151095CompletedNot Applicable

Examining The Effect of Blood Flow Restricted Aerobic Training on Citrate Synthase Activity in Young Healthy Adults

Brendon Gurd, PhD1 site in 1 country19 target enrollmentStarted: May 6, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
19
Locations
1
Primary Endpoint
Citrate Synthase

Study Overview

Brief Summary

This parallel-arm trial study investigates the effects of restricting arterial blood flow during cycling exercise on citrate synthase. Participants will be randomized to either a blood flow restricted or non-blood flow restricted exercise training group. Both groups will complete seven, 30-minute exercise sessions over a 14-day period.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Allocation concealment, assessor blinding

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 3 hours of physical activity per week
  • No previous cycling training
  • No concurrent involvement in another training program
  • Body mass index < 30 kg/m2

Exclusion Criteria

  • Presence of cardiovascular disease
  • Presence of metabolic disease
  • Taking regular oral medication
  • Current smoker

Arms & Interventions

BFR

Experimental

Intervention: BFR Exercise Training (Other)

CTL

Experimental

Intervention: CTL Exercise Training (Other)

Outcomes

Primary Outcomes

Citrate Synthase

Time Frame: 3 days prior to start of exercise training and 3 days after completing exercise training

Fold change in citrate synthase maximal activity

Secondary Outcomes

  • Heart rate (HR)(Every 5 minutes during each of the 7, 30-minute exercise sessions)
  • Rating of perceived exertion (RPE)(Every 5 minutes during each of the 7, 30-minute exercise sessions)
  • Nuclear Factor, Erythroid 2 Like 2 (NFE2L2)(3 days before training to 3 days after training)
  • Transcription factor A, mitochondrial (TFAM)(3 days before training to 3 days after training)
  • Maximal oxygen consumption (VO2peak)(3 days before training to 3 days after training)
  • Revolutions per minute (RPM)(Every 5 minutes during each of the 7, 30-minute exercise sessions)
  • Blood [lactate](During all exercise sessions at 10 and 30 minutes)
  • Cytochrome c oxidase (COX)(3 days before training to 3 days after training)
  • Electromyography (EMG)(Throughout each of the 7, 30-minute exercise sessions)
  • Near-infrared spectroscopy (NIRS)(Throughout each of the 7, 30-minute exercise sessions)
  • Nuclear respiratory factor, 1 (NRF1)(3 days before training to 3 days after training)

Investigators

Sponsor
Brendon Gurd, PhD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Brendon Gurd, PhD

Associate Professor

Queen's University

Study Sites (1)

Loading locations...

Similar Trials